NTRA
Natera, Inc.
56.58
USD
This page is just a preview of the data found in TrendSpider’s full version
Natera, Inc. stock is up 43.35% since 30 days ago. The next earnings date is Feb 27, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 44.44% of the previous 8 November’s closed higher than October. In the last 10 Unusual Options Trades, there were 8 CALLs, 2 PUTs. 100% of analysts rate it a buy.
| Date & Time | Expiration Date | Strike Price | Trade Type | Size | Open Interest |
|---|---|---|---|---|---|
| 02 Oct 16:19 | 19 Jan, 2024 | 50.00 | 10 | ||
| 02 Oct 16:19 | 19 Jan, 2024 | 50.00 | 10 | ||
| 02 Oct 16:21 | 17 Nov, 2023 | 45.00 | 0 | ||
| 12 Oct 19:41 | 20 Oct, 2023 | 40.00 | 8 | ||
| 17 Oct 19:45 | 19 Jan, 2024 | 50.00 | 3489 | ||
| 20 Oct 17:52 | 17 Nov, 2023 | 40.00 | 36 | ||
| 23 Oct 18:59 | 17 Nov, 2023 | 45.00 | 1111 | ||
| 09 Nov 15:42 | 19 Apr, 2024 | 45.00 | 68 | ||
| 13 Nov 15:56 | 19 Apr, 2024 | 55.00 | 20 | ||
| 29 Nov 18:20 | 19 Jan, 2024 | 50.00 | 4440 |
Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity. The company also provides Anora miscarriage test products to analyze fetal chromosomes to understand the cause of miscarriage.
